InvestorsHub Logo
Followers 90
Posts 17409
Boards Moderated 0
Alias Born 09/06/2006

Re: BioBS2012 post# 268006

Tuesday, 07/12/2016 5:30:57 AM

Tuesday, July 12, 2016 5:30:57 AM

Post# of 345989
AEs, P2 NSCLC table

One has to look closely. Note that you must go by percents (as the combined arm was twice as many N as 3Mg) and also the table is orderd by control arm AEs, thus if one just looks at the top AEs they miss some real data.

Below is the chart simplified to % and ordered by the sum of the % ARs.

It certainly looks like Bavi does have some side effects, and with bavi also on the comparator arm (it was blended) which confounds the data somewhat.

They certainly were mainly grade 1-2, so I would not argue with PPHM saying they were minor and well tolerated. But the question raised by entdoc was if there were none, which would be very stange, and is not well supported by this data.

AE 3MG 1+0mg
Nausea 37.5 27.8 *
Neutropenia 32.5 24.1 *
Cough 25.0 21.5 *
Asthemia 30.0 16.5 *
Anemia 25.0 17.7 *
Anorexia 27.0 15.2 *
Diarhia 17.5 20.3 X
Alopecia 20.0 17.7 X
Fatague 35.0 29.1 *
Pyrexia 20.0 16.5 *
Edema 15.0 20.3 *
Constipatiom 17.5 15.2 *
Ayrthralgia 20.0 10.1 *
Chest Pain 20.0 10.1 *
Back Pain 10.0 10.1
Dyspnea 12.5 13.9
Vomiting 15.0 11.4 *
Pro. Cough 17.5 8.9 *
Leukopenia 10.0 15.2 X
Hypotension 15.0 5.1 *
Pain Extremity 12.5 10.1 *
Per Neuropothy 10.0 8.9 X
Headach 7.5 10.1 X
Dizziness 10.0 7.6 *
Weight Loss 10.0 6.3 *
Dyspnea 10.0 6.3 *
Abd. Pain 12.5 3.9 *
Dehydration 10.0 5.1 *
Stammaitis 10.0 5.1 *
Mucosol Inflam. 12.5 2.5 *

* indicates more than a 2% diff with 3mg worse, X = combined arms 2% worse


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News